These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 30711937

  • 1. Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of 18FDG PET-CT.
    Legros M, Margueritte F, Tardieu A, Deluche E, Mbou VB, Lacorre A, Ceuca A, Aubard Y, Monteil J, Sallee C, Gauthier T.
    Anticancer Res; 2019 Feb; 39(2):619-625. PubMed ID: 30711937
    [Abstract] [Full Text] [Related]

  • 2. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY, Lee JJ, Choi HJ, Song IH, Sung CO, Kim HO, Chae SY, Kim YT, Nam JH.
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [Abstract] [Full Text] [Related]

  • 3. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
    Konuralp Atakul B, Taşkın S, Soydal Ç, Sükür YE, Kahraman A, Koyuncu K, İbiş E, Ortac F.
    Gynecol Obstet Invest; 2017 Aug; 82(4):340-348. PubMed ID: 27771729
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of preoperative 18F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis.
    Hu J, Zhang K, Yan Y, Zang Y, Wang Y, Xue F.
    Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242
    [Abstract] [Full Text] [Related]

  • 5. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T, Terai Y, Yamamoto K, Yamada T, Ohmichi M.
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging.
    Mayoral M, Paredes P, Domènech B, Fusté P, Vidal-Sicart S, Tapias A, Torné A, Pahisa J, Ordi J, Pons F, Lomeña F.
    Rev Esp Med Nucl Imagen Mol; 2017 Sep; 36(1):20-26. PubMed ID: 27667001
    [Abstract] [Full Text] [Related]

  • 7. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
    Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell'Anna T, Sironi S, Messa C.
    Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
    [Abstract] [Full Text] [Related]

  • 8. A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer.
    Aşıcıoğlu O, Gungorduk K, Ozdemir A, Güngördük Ö, Gokçü M, Yaşar L, Sancı M.
    J Obstet Gynaecol; 2019 Jan; 39(1):105-109. PubMed ID: 30187784
    [Abstract] [Full Text] [Related]

  • 9. False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
    Gouy S, Seebacher V, Chargari C, Terroir M, Grimaldi S, Ilenko A, Maulard A, Genestie C, Leary A, Pautier P, Morice P, Deandreis D.
    BMC Cancer; 2021 Feb 06; 21(1):135. PubMed ID: 33549033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, Uzan C, Lumbroso S, Lecuru F, Bats AS, Ghazzar N, Bannier M, Houvenaeghel G, Brenot-Rossi I, Narducci F.
    Ann Surg Oncol; 2011 Aug 06; 18(8):2302-9. PubMed ID: 21347790
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
    Nogami Y, Banno K, Irie H, Iida M, Kisu I, Masugi Y, Tanaka K, Tominaga E, Okuda S, Murakami K, Aoki D.
    Jpn J Clin Oncol; 2015 Jan 06; 45(1):26-34. PubMed ID: 25368102
    [Abstract] [Full Text] [Related]

  • 14. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
    Taşkin S, Varli B, Ersöz CC, Altin D, Soydal Ç, Ortaç F.
    Nucl Med Commun; 2020 Apr 06; 41(4):389-394. PubMed ID: 31939903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C.
    Gynecol Oncol; 2013 Aug 06; 130(2):306-11. PubMed ID: 23707673
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
    Yeh LS, Hung YC, Shen YY, Kao CH, Lin CC, Lee CC.
    Oncol Rep; 2002 Aug 06; 9(6):1289-92. PubMed ID: 12375036
    [Abstract] [Full Text] [Related]

  • 20. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Dräger DL, Heuschkel M, Protzel C, Erbersdobler A, Krause BJ, Hakenberg OW, Schwarzenböck SM.
    Nuklearmedizin; 2018 Feb 06; 57(1):26-30. PubMed ID: 29536497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.